Product NDC: | 33342-035 |
Proprietary Name: | Pramipexole dihydrochloride |
Non Proprietary Name: | Pramipexole dihydrochloride |
Active Ingredient(s): | 1.5 mg/1 & nbsp; Pramipexole dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 33342-035 |
Labeler Name: | Macleods Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202164 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120921 |
Package NDC: | 33342-035-12 |
Package Description: | 100 TABLET in 1 BLISTER PACK (33342-035-12) |
NDC Code | 33342-035-12 |
Proprietary Name | Pramipexole dihydrochloride |
Package Description | 100 TABLET in 1 BLISTER PACK (33342-035-12) |
Product NDC | 33342-035 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pramipexole dihydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120921 |
Marketing Category Name | ANDA |
Labeler Name | Macleods Pharmaceuticals Limited |
Substance Name | PRAMIPEXOLE DIHYDROCHLORIDE |
Strength Number | 1.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |